angiotensin ii has been researched along with Carcinoma, Pancreatic Ductal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordopatis, P; Inui, M; Ishiguro, S; Kawabata, A; Magafa, V; Oka, M; Takao, S; Tamura, M; Tsunedomi, R; Tzakos, AG; Wall, T; Yoshimura, K | 1 |
| Qian, A; Qiao, M; Wang, J; Yao, W; Yuan, Y; Zhang, R; Zhang, Y; Zhou, L | 1 |
| Gutierréz-Reyes, G; Guzmán, C; Hiriart, M; Olivares-Reyes, JA; Pérez-Díaz, I; Ramírez, T; Robles-Díaz, G | 1 |
| Amaya, K; Fujimura, T; Fushida, S; Kayahara, M; Kitagawa, H; Miwa, K; Ninomiya, I; Nishimura, G; Ohta, T; Shimizu, K; Yi, S | 1 |
| Arafat, HA; Chipitsyna, G; Gong, Q; Rizvi, A; Saa, CT; Yeo, CJ | 1 |
| Anandanadesan, R; Arafat, HA; Chipitsyna, G; Gong, Q; Witkiewicz, A; Yeo, CJ | 1 |
6 other study(ies) available for angiotensin ii and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Topics: Angiotensin II; Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Gene Expression; Humans; Immunohistochemistry; Mice; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Transplantation, Isogeneic; Tumor Burden; Tumor Stem Cell Assay | 2015 |
Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Disease Progression; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Protein Transport; RNA Interference | 2009 |
Evidence of an intracellular angiotensin-generating system and non-AT1, non-AT2 binding site in a human pancreatic cell line.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Binding Sites; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Humans; Intracellular Space; Losartan; Pancreatic Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Endothelial Growth Factor A | 2011 |
Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues.
Topics: Angiotensin II; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Chymases; Colonic Neoplasms; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Liver Neoplasms; Mast Cells; Pancreas; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Serine Endopeptidases; Trypsin | 2003 |
Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blotting, Western; Carcinoma, Pancreatic Ductal; Chi-Square Distribution; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Neovascularization, Pathologic; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Vascular Endothelial Growth Factor A | 2007 |
Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Disease Progression; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Genistein; Humans; Imidazoles; Immunohistochemistry; Losartan; Mitogen-Activated Protein Kinase 1; Neovascularization, Pathologic; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Vascular Endothelial Growth Factor A; Vasoconstrictor Agents | 2008 |